How come Najarian from CNBC picked CLSN as his number 1 ASCO pick ?
That hatchet job on SA yesterday, and Adam Feuerstien contend that Celsion was not at ASCO, yet a CNBC reporter named CLSN as his number 1 pick to BY before ASCO. Now we see proof on the new SA article today that Celsion was in deed at ASCO and had a booth just 3 over from Glaxo Smith Kline?
What kind of paid hatchet job did that short seller do on SA yesterday? Who paid him to do it? Will his lies be prosecuted? These are the questions that need to be asked and accounted for. Call the company, call the SEC. Lodge your complaints.
Buy your stock back cheaper here if you sold on that article. Some Luck trader bought back at $1 premarket...hahahaha, and they were probably the ones behind the article. When the market opens the real buyers will step in LARGE, and probably drive CLSN above yesterdays highs.
CELSION WILL PRESENT THE TRIAL FINDINGS IN TWO SEPERATE PRESENTATIONS IN EUROPE AT WCIO on Jun 19-22
THAT"S THE FACT.
They won't travel to Europe and have 2 presentations to talk about failure. NO ONE DOES THAT.